EA202092007A1 - Способ лечения острого респираторного дистресс-синдрома взрослых при инфекции covid-19 - Google Patents
Способ лечения острого респираторного дистресс-синдрома взрослых при инфекции covid-19Info
- Publication number
- EA202092007A1 EA202092007A1 EA202092007A EA202092007A EA202092007A1 EA 202092007 A1 EA202092007 A1 EA 202092007A1 EA 202092007 A EA202092007 A EA 202092007A EA 202092007 A EA202092007 A EA 202092007A EA 202092007 A1 EA202092007 A1 EA 202092007A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- covid
- acute respiratory
- lungs
- adults
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H31/00—Artificial respiration or heart stimulation, e.g. heart massage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к области медицины, а именно к анестезиологии и реаниматологии, и используется для профилактики и лечения острой дыхательной недостаточности при вирусной этиологии заболевания (COVID-19) препаратом Сурфактант (Curosurf). Препарат применяется в дозе 200-400 мг одномоментно эндотрахеально. Вводится при условии интубации и осуществляемой искусственной вентиляции легких в начале фазы вдоха для более эффективного альвеолярного распределения. Введение осуществляется 1 раз в сутки. Рекомендуется вводить 4-5 доз, общая дозировка на курс лечения - 800-2000 мг. Предлагаемый способ обладает высокой эффективностью для лечения острого респираторного дистресс-синдрома взрослых, позволяет в короткие сроки повысить дыхательную функцию легких у пациентов с COVID-19, находящихся на искусственной вентиляции легких. Позволяет сократить сроки искусственной вентиляции легких и пребывания больных в палате интенсивной терапии.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA202092007A EA202092007A1 (ru) | 2020-05-06 | 2020-05-06 | Способ лечения острого респираторного дистресс-синдрома взрослых при инфекции covid-19 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA202092007A EA202092007A1 (ru) | 2020-05-06 | 2020-05-06 | Способ лечения острого респираторного дистресс-синдрома взрослых при инфекции covid-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202092007A1 true EA202092007A1 (ru) | 2021-11-30 |
Family
ID=78750225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202092007A EA202092007A1 (ru) | 2020-05-06 | 2020-05-06 | Способ лечения острого респираторного дистресс-синдрома взрослых при инфекции covid-19 |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA202092007A1 (ru) |
-
2020
- 2020-05-06 EA EA202092007A patent/EA202092007A1/ru unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Johannesson et al. | Sevoflurane for ENT‐surgery in children A comparison with halothane | |
Holley et al. | Vocal cord paralysis after tracheal intubation | |
Doyle et al. | Anaesthesia for primary repair of cleft lip and cleft palate: a review of 244 procedures | |
Herrick et al. | Postobstructive pulmonary edema following anesthesia | |
Staffel et al. | The prevention of postoperative stridor and laryngospasm with topical lidocaine | |
Osserman et al. | Studies in myasthenia gravis: reduction in mortality rate after crisis | |
Hernández-Cortez | Update on the management of laryngospasm | |
MacDonnell et al. | Adrenaline administered via a nebulizer in adult patients with upper airway obstruction | |
Scarbrough et al. | Pulmonary edema following postoperative laryngospasm: case reports and review of the literature. | |
Bush | Prolonged neuromuscular block due to intraperitoneal streptomycin | |
EA202092007A1 (ru) | Способ лечения острого респираторного дистресс-синдрома взрослых при инфекции covid-19 | |
Breivik et al. | Acute epiglottitis in children: review of 27 patients | |
Voelker et al. | Resolution of recurrent atelectasis in spinal cord injury patients with administration of recombinant human DNase | |
Nath et al. | The laryngeal mask in the management of a paediatric difficult airway | |
Inglis | Herpes simplex virus infection: a rare cause of prolonged croup | |
Williams et al. | The practical management of severe status asthmaticus | |
Takeshita et al. | Anesthetic management of a patient with Cornelia De Lange syndrome | |
D’souza et al. | Perioperative laryngospasm-review of literature | |
Epstein et al. | Experiences with low tracheostomy in the burn patient | |
Altinsoy et al. | The effects of topical chlorhexidine-benzydamine spray on laryngeal mask airway application | |
Mikkelsen et al. | Pneumopericardium associated with high-frequency jet ventilation during laser surgery of the hypopharynx in a child | |
Woloszczuk-Gebicka | RSII rapid-sequence induction of anaesthesia and intubation of the trachea | |
Diaz-Abad et al. | Use of non-invasive ventilation to facilitate extubation in a patient with amyotrophic lateral sclerosis with hypercapnic respiratory failure | |
RU2713838C1 (ru) | Способ анестезиологического обеспечения при селективной доставке химиопрепарата к сетчатке глаза при лечении интраокулярной ретинобластомы у детей | |
Oliynyk et al. | ThE INfLUENcE Of dIffERENT vENTILATION PATTERNs ON TREATmENT Of PATIENTs WITh sEvERE TRAUmATIc BRAIN INJURY |